Infinity Pharmaceuticals Inc (INFI)
0.90
-0.03 -2.70%
NASDAQ
May 29, 20:00
Delayed 2m
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 1.336M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -0.77 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -44.20M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 39.72% |
| Profit Margin (Quarterly) | -2.54K% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0.00% |
| Price and Valuation | |
| Market Cap | 51.69M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 38.46 |
| PE Ratio | -- |
| Price to Book Value | -- |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | -21.86 |
| Free Cash Flow (Quarterly) | -11.80M |
| Return on Equity | Upgrade |
View All INFI News
News
-
WireHeadlineTime (ET)
-
MT Newswires05/18 10:27
-
Yahoo05/18 07:45
-
Yahoo05/12 12:48
-
MT Newswires05/12 09:37
-
Yahoo05/11 08:55
-
SA Breaking News05/11 07:38
-
Business Wire05/11 07:35
-
Business Wire05/04 07:35
-
Yahoo04/28 12:33
-
Yahoo04/20 07:59
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 07/30/2020 08:00 EDT | Misc | Infinity Pharmaceuticals Inc Second Quarter Earnings Conference Call in 2020 |
| 07/30/2020 | Earnings | Infinity Pharmaceuticals Inc Second Quarter Earnings in 2020 Release |
| 06/17/2020 | Misc | Infinity Pharmaceuticals Inc Annual General Meeting for 2019 |
| 05/11/2020 16:30 EDT | Misc | Infinity Pharmaceuticals Inc First Quarter Earnings Conference Call for 2020 |
| 05/11/2020 | Earnings | Infinity Pharmaceuticals Inc First Quarter Earnings Result for 2020 |
| 03/03/2020 16:30 EST | Misc | Infinity Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 2019 |
| 03/03/2020 | Earnings | Infinity Pharmaceuticals Inc Fourth Quarter Earnings in 2019 Release |
| 03/03/2020 | Misc | Infinity Pharmaceuticals Inc Annual Report for 2019 |
| 10/30/2019 16:30 EDT | Misc | Infinity Pharmaceuticals Inc Third Quarter Earnings Conference Call for 2019 |
| 10/30/2019 | Earnings | Infinity Pharmaceuticals Inc Third Quarter Earnings in 2019 Release |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: http://www.infi.com
- Investor Relations URL: http://phx.corporate-ir.net/phoenix.zhtml?c=121941&p=irol-irhome
- HQ State/Province: Massachusetts
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Small Cap/Blend
- Next Earnings Release: Jul. 30, 2020
- Last Earnings Release: May. 11, 2020
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Infinity Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing novel medicines for the treatment of specific cancers. The company's developed products and those under development include therapies targeting hematologic malignancies, or blood cancers; refractory indolent non-Hodgkin lymphoma; refractory chronic lymphocytic leukemia; and solid tumors, including melanoma and non-small cell lung cancer. Infinity has a strategic partnership with AbbVie to develop some of its oncology-related treatments. The company operates in only one segment which is drug development.
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 0.90 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- INFI Tweets Stocktwits
Advertisement
